Analyst firms · J.P. Morgan · RMD

J.P. Morgan RMD price target and rating history

ResMed Inc. (RMD) · Health Care

J.P. Morgan rates ResMed Inc. (RMD) Overweight with a $170 price target, as of its latest action on Oct 9, 2023. It has published 6 rating actions on RMD since July 2021, including 4 upgrades and 2 downgrades. Across 5 firms with a RMD price target in the last 12 months, the median target is $235.

Current rating
Overweight
Price target
$170
Median target, all firms
$235
Actions on RMD
6

J.P. Morgan price target on RMD

$270$220$17020222023202420252026
J.P. Morgan price target on RMD, each point a stated target, July 2021 to October 2023.

Every J.P. Morgan rating on RMD

How other firms rate RMD

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Canaccord GenuityHoldNov 2, 2026
RBC Capital MarketsOutperform$262Sep 15, 2026
Rothschild & Co RedburnNeutral$230Aug 19, 2026
CitigroupNeutral$235Jul 13, 2026
Morgan StanleyEqual-Weight$230Jun 17, 2026
Robert W. BairdNeutral$275Dec 16, 2025

Questions about J.P. Morgan and RMD

What is J.P. Morgan's price target for RMD?
J.P. Morgan's latest stated price target for ResMed Inc. (RMD) is $170, from its action on Oct 9, 2023.
What is J.P. Morgan's rating on RMD?
J.P. Morgan rates RMD Overweight, a bullish rating, as of Oct 9, 2023.
When did J.P. Morgan last change its view on RMD?
On Oct 9, 2023, J.P. Morgan upgrades to Overweight from Neutral, price target $210 to $170.
How does J.P. Morgan's RMD target compare with other analysts?
Across 5 firms with a RMD price target in the last 12 months, the median target is $235.

More RMD rating histories

All J.P. Morgan ratingsRMD news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.